A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

Background: Persistent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has given rise to a COVID-19 pandemic. Several vaccines, conceived in 2020, that evoke protective spike antibody responses are being deployed in mass public health vaccination programs. Recent data su...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Paul E., Brasel, Trevor, Massey, Christopher, Herst, C. V., Burkholz, Scott, Lloyd, Peter, Blankenberg, Tikoes, Bey, Thomas M., Carback, Richard, Hodge, Thomas, Ciotlos, Serban, Wang, Lu, Comer, Jason E., Rubsamen, Reid M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158516/
https://www.ncbi.nlm.nih.gov/pubmed/34070152
http://dx.doi.org/10.3390/vaccines9050520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158516/
https://www.ncbi.nlm.nih.gov/pubmed/34070152
http://dx.doi.org/10.3390/vaccines9050520

Ejemplares similares